Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AMDANASDAQ:APOPOTCMKTS:ECIAOTCMKTS:RGIN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMDAAmedica$0.05$0.26$0.18▼$6.40$588K-1.241.07 million shs8.23 million shsAPOPCellect Biotechnology$13.17+0.4%$11.51$6.64▼$35.52$12.87M1.87479,845 shs17,400 shsECIAEncision$0.75$0.46$0.25▼$0.75$8.83M0.282,180 shsN/ARGINRegenicin$0.00$0.00▼$0.00$20KN/A1.80 million shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMDAAmedica+0.61%-63.60%-63.84%-87.02%-97.82%APOPCellect Biotechnology0.00%0.00%0.00%0.00%0.00%ECIAEncision+50.00%+50.00%+63.76%+76.47%+79.00%RGINRegenicin0.00%0.00%0.00%0.00%-92.86%Altcoin FRENZY Alert… (Ad)Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!)MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMDAAmedicaN/AN/AN/AN/AN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMDAAmedicaN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMDAAmedica$11.23M0.05N/AN/A$1.80 per share0.03APOPCellect BiotechnologyN/AN/AN/AN/A$4.77 per shareN/AECIAEncision$7.35M1.20N/AN/A$0.21 per share3.57RGINRegenicinN/AN/AN/AN/A($0.04) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMDAAmedica-$9.32M-$3.13N/AN/AN/A-139.62%-148.60%-67.83%N/AAPOPCellect Biotechnology-$5.62MN/A0.00∞N/AN/AN/AN/AN/AECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)RGINRegenicin-$640KN/A0.00N/AN/AN/AN/AN/AN/ALatest APOP, RGIN, ECIA, and AMDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMDAAmedicaN/AN/AN/AN/AN/AAPOPCellect BiotechnologyN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMDAAmedicaN/A1.110.99APOPCellect BiotechnologyN/A3.013.01ECIAEncision0.112.551.08RGINRegenicinN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMDAAmedica3.72%APOPCellect Biotechnology4.84%ECIAEncision8.20%RGINRegenicin0.01%Insider OwnershipCompanyInsider OwnershipAMDAAmedica0.90%APOPCellect BiotechnologyN/AECIAEncision40.87%RGINRegenicinN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMDAAmedicaN/A11.87 millionN/ANot OptionableAPOPCellect Biotechnology2,020977,000N/ANot OptionableECIAEncision3111.78 million6.96 millionNot OptionableRGINRegenicin3165.77 millionN/ANot OptionableAPOP, RGIN, ECIA, and AMDA HeadlinesSourceHeadlineSevere cold front hits central, eastern regions; schools forced to delay start of new semesterglobaltimes.cn - February 21 at 10:59 PMPalworld map – all locations, regions, and points of interestpcgamesn.com - February 2 at 10:38 AMAlexander boys fend off top challenger in Region 5ajc.com - January 30 at 7:33 PMJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'foxnews.com - January 20 at 12:10 AMJournal of the History of Economic Thoughtcambridge.org - January 7 at 7:36 AMHistory of computers: A brief timelinelivescience.com - December 24 at 7:27 PMWATCH: Blue Origin successfully launches rocket in first flight since 2022 crashwlwt.com - December 21 at 3:37 PMBlue Origin successfully completes rocket mission more than a year after failed launchnydailynews.com - December 21 at 3:37 PMBlue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video)space.com - December 20 at 5:23 PMJeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 monthsgeekwire.com - December 20 at 5:23 PMHistory of Walmart: Timeline and Factsthestreet.com - December 9 at 1:54 PMRegion police calls – Nov. 28therepublic.com - December 1 at 12:05 AMAir defenses destroy 11 Ukrainian drones over four Russian regionstass.com - November 27 at 10:05 PMNew Regions Bank coming to Kingsporttimesnews.net - November 21 at 6:09 PMFlorida high school football playoffs: A look at 5 wide open regions in the statetheledger.com - November 16 at 7:42 PMFlorida high school football playoffs: A look at the 5 deepest regions in the stategainesville.com - November 13 at 7:55 AMThe 12 Regions of China: Past and Presentthediplomat.com - October 28 at 7:48 AMVHSL power ratings | Green Run, Maury, Phoebus all lead their regions at midseasonpilotonline.com - October 6 at 11:34 PMTurtle Shells Record Nuclear Historyscientificamerican.com - September 14 at 9:47 PMDrones target six regions in largest drone attack on Russian soil since start of war in Ukrainenbcbayarea.com - September 7 at 4:29 PMNolensville Little League vs. Smithfield, Rhode Island: Little League World Series score, updatestennessean.com - September 6 at 5:21 AMRoad Trip of the Regionseducation.com - September 4 at 4:37 PMHeavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 deadfoxnews.com - August 22 at 6:41 PMLeveraging Urbanization in South Asiaworldbank.org - July 21 at 12:23 AMTop Headlines4 Stocks to Buy Before the Fed Cuts Interest RatesMarch 19, 2024 7:49 AMView 4 Stocks to Buy Before the Fed Cuts Interest RatesIs it Time to Buy These 5 Oversold Stocks?March 15, 2024 7:12 AMView Is it Time to Buy These 5 Oversold Stocks?4 Oversold Large Cap Stocks Yielding High DividendsMarch 14, 2024 6:30 AMView 4 Oversold Large Cap Stocks Yielding High DividendsActive Rebound: 2 Discrete Semiconductor Stocks Making MovesMarch 12, 2024 8:00 AMView Active Rebound: 2 Discrete Semiconductor Stocks Making MovesPalantir Stock Spikes 6% on U.S. Army TITAN ContractMarch 6, 2024 12:33 PMView Palantir Stock Spikes 6% on U.S. Army TITAN ContractAll Headlines Company DescriptionsAmedicaNASDAQ:AMDASINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.Cellect BiotechnologyNASDAQ:APOPCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.RegenicinOTCMKTS:RGINRegenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.